20 results
6-K
EX-99.1
OBSVF
ObsEva SA
23 Mar 20
ObsEva Provides Update Related to COVID-19 Pandemic
4:00pm
.”
ObsEva is working diligently with clinical sites, following regulatory, ethics committee, and health agency guidance related to the COVID-19 pandemic
10-K
2022 FY
OBSVF
ObsEva SA
31 Mar 23
Annual report
4:01pm
trials may begin. The sponsor must update the IND annually;
approval of the study by an institutional review board (“IRB”) or ethics committee at each … their ownership of our securities. Our Code of Ethics, and any amendments to our Code of Ethics, are also available on our website under the “Investors
20-F
wv5cqfn 2lz
21 Apr 17
Annual report (foreign)
12:00am
6-K
EX-99.1
ufhyw
7 Aug 19
Current report (foreign)
7:21am
F-3
s6u63eqr2a hmclgsljj
7 Aug 19
Shelf registration (foreign)
8:24am
DRS
pwve6b9
14 Oct 16
Draft registration statement
12:00am
F-1
es6q5zr322
30 Dec 16
Registration statement (foreign)
12:00am
F-3
upfgnig 97hek08
9 Dec 22
Shelf registration (foreign)
7:06am
424B5
o8rj6xzw7ysa
5 Mar 21
Prospectus supplement for primary offering
7:55am
424B5
jxj7y69
18 Jun 18
Prospectus supplement for primary offering
9:15pm
424B5
fxz6i 46m4c4jdipd
20 Jun 18
Prospectus supplement for primary offering
5:32pm
424B5
sals1ypb9ff7dfxiw0
7 Aug 19
Prospectus supplement for primary offering
8:18am
424B5
ahoc1xmyd0eqqflddlzz
8 Sep 20
Prospectus supplement for primary offering
7:31am
- Prev
- 1
- Next